202 related articles for article (PubMed ID: 12952307)
21. Current status and recent advances in reirradiation of glioblastoma.
Minniti G; Niyazi M; Alongi F; Navarria P; Belka C
Radiat Oncol; 2021 Feb; 16(1):36. PubMed ID: 33602305
[TBL] [Abstract][Full Text] [Related]
22. Radiosurgery for primary malignant brain tumors.
Alexander E; Loeffler JS
Semin Surg Oncol; 1998; 14(1):43-52. PubMed ID: 9407630
[TBL] [Abstract][Full Text] [Related]
23. [Radiation therapy for brain tumors].
Tanaka Y; Fujii M; Saito T; Kawamori J
Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Sep; 64(7):387-93. PubMed ID: 15688744
[TBL] [Abstract][Full Text] [Related]
24. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
25. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
26. Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.
Clarke JW; Chang EL; Levin VA; Mayr NA; Hong E; Cavaliere R; Lo SS
Expert Rev Anticancer Ther; 2008 May; 8(5):733-41. PubMed ID: 18471046
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy.
Aiken AH; Chang SM; Larson D; Butowski N; Cha S
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1340-6. PubMed ID: 18538496
[TBL] [Abstract][Full Text] [Related]
28. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
Park I; Tamai G; Lee MC; Chuang CF; Chang SM; Berger MS; Nelson SJ; Pirzkall A
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):381-9. PubMed ID: 17513061
[TBL] [Abstract][Full Text] [Related]
29. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
Kong DS; Nam DH; Lee JI; Park K; Kim JH
J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
[TBL] [Abstract][Full Text] [Related]
30. High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes.
Chang CN; Chen WC; Wei KC; Ng SH; Ho YS; Huang DY; Lee SP; Hong JH
J Neurooncol; 2003 Jan; 61(1):45-55. PubMed ID: 12587795
[TBL] [Abstract][Full Text] [Related]
31. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
[TBL] [Abstract][Full Text] [Related]
32. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
Iuchi T; Hatano K; Kodama T; Sakaida T; Yokoi S; Kawasaki K; Hasegawa Y; Hara R
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):793-800. PubMed ID: 24495592
[TBL] [Abstract][Full Text] [Related]
33. [Radiotherapy of glioblastoma].
de Crevoisier R; Pierga JY; Dendale R; Feuvret L; Noël G; Simon JM; Mazeron JJ
Cancer Radiother; 1997; 1(3):194-207. PubMed ID: 9295873
[TBL] [Abstract][Full Text] [Related]
34. [Value of radiosurgery in first-line therapy of glioblastoma multiforme. The Heidelberg experience and review of the literature].
van Kampen M; Engenhart-Cabillic R; Debus J; Fuss M; Rhein B; Wannenmacher M
Strahlenther Onkol; 1998 Apr; 174(4):187-92. PubMed ID: 9581178
[TBL] [Abstract][Full Text] [Related]
35. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.
Shrieve DC; Alexander E; Black PM; Wen PY; Fine HA; Kooy HM; Loeffler JS
J Neurosurg; 1999 Jan; 90(1):72-7. PubMed ID: 10413158
[TBL] [Abstract][Full Text] [Related]
36. Effects of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy.
Siddiqi SN; Provias J; Laperriere N; Bernstein M
Neurosurgery; 1997 May; 40(5):910-7; discussion 917-8. PubMed ID: 9149248
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
[TBL] [Abstract][Full Text] [Related]
38. Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma.
Nieder C; Mehta MP
Med Hypotheses; 2011 Mar; 76(3):410-3. PubMed ID: 21112157
[TBL] [Abstract][Full Text] [Related]
39. Radiosurgery/stereotactic external beam radiotherapy for malignant brain tumours: the Royal Marsden Hospital experience.
Brada M; Laing R
Recent Results Cancer Res; 1994; 135():91-104. PubMed ID: 7519356
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang JE; Khuntia D; Robins HI; Mehta MP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
